Oxaloterpin C

Details

Top
Internal ID 3ecf0748-9ff9-474e-88d2-26b579a7a693
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids
IUPAC Name [(2R,4aR,7S,8aS,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2H-phenanthren-2-yl] 2-(hydroxyamino)-2-oxoacetate
SMILES (Canonical) CC1(C2CCC3CC(CC=C3C2(CCC1OC(=O)C(=O)NO)C)(C)C=C)C
SMILES (Isomeric) C[C@@]12CC[C@H](C([C@H]1CC[C@@H]3C2=CC[C@](C3)(C)C=C)(C)C)OC(=O)C(=O)NO
InChI InChI=1S/C22H33NO4/c1-6-21(4)11-9-15-14(13-21)7-8-16-20(2,3)17(10-12-22(15,16)5)27-19(25)18(24)23-26/h6,9,14,16-17,26H,1,7-8,10-13H2,2-5H3,(H,23,24)/t14-,16+,17+,21-,22-/m0/s1
InChI Key CXFLMGBDJGYAAS-OIRDONMBSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C22H33NO4
Molecular Weight 375.50 g/mol
Exact Mass 375.24095853 g/mol
Topological Polar Surface Area (TPSA) 75.60 Ų
XlogP 5.80
Atomic LogP (AlogP) 4.17
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Oxaloterpin C

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9718 97.18%
Caco-2 - 0.6317 63.17%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Plasma membrane 0.4088 40.88%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9141 91.41%
OATP1B3 inhibitior + 0.9145 91.45%
MATE1 inhibitior - 0.7200 72.00%
OCT2 inhibitior - 0.7572 75.72%
BSEP inhibitior + 0.6103 61.03%
P-glycoprotein inhibitior - 0.5457 54.57%
P-glycoprotein substrate - 0.7942 79.42%
CYP3A4 substrate + 0.6474 64.74%
CYP2C9 substrate - 0.8062 80.62%
CYP2D6 substrate - 0.8757 87.57%
CYP3A4 inhibition - 0.7907 79.07%
CYP2C9 inhibition - 0.7145 71.45%
CYP2C19 inhibition - 0.7216 72.16%
CYP2D6 inhibition - 0.8981 89.81%
CYP1A2 inhibition - 0.7594 75.94%
CYP2C8 inhibition + 0.5743 57.43%
CYP inhibitory promiscuity - 0.8639 86.39%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.7043 70.43%
Carcinogenicity (trinary) Non-required 0.5383 53.83%
Eye corrosion - 0.9822 98.22%
Eye irritation - 0.9717 97.17%
Skin irritation - 0.7107 71.07%
Skin corrosion - 0.9216 92.16%
Ames mutagenesis - 0.7400 74.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7958 79.58%
Micronuclear + 0.6200 62.00%
Hepatotoxicity - 0.5685 56.85%
skin sensitisation - 0.8127 81.27%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.8778 87.78%
Mitochondrial toxicity + 0.7125 71.25%
Nephrotoxicity - 0.6283 62.83%
Acute Oral Toxicity (c) III 0.5828 58.28%
Estrogen receptor binding + 0.8965 89.65%
Androgen receptor binding + 0.5483 54.83%
Thyroid receptor binding + 0.7309 73.09%
Glucocorticoid receptor binding + 0.8357 83.57%
Aromatase binding + 0.7901 79.01%
PPAR gamma + 0.6492 64.92%
Honey bee toxicity - 0.7878 78.78%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.5700 57.00%
Fish aquatic toxicity + 0.9956 99.56%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.03% 96.09%
CHEMBL221 P23219 Cyclooxygenase-1 95.93% 90.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.02% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.39% 94.45%
CHEMBL340 P08684 Cytochrome P450 3A4 86.98% 91.19%
CHEMBL5028 O14672 ADAM10 85.18% 97.50%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.97% 95.56%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 81.87% 95.50%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.45% 95.89%
CHEMBL2581 P07339 Cathepsin D 81.30% 98.95%

Cross-Links

Top
PubChem 24178994
NPASS NPC242275
LOTUS LTS0204120
wikiData Q77569168